ID   CATA_HUMAN              Reviewed;         527 AA.
AC   P04040; A8K6C0; B2RCZ9; D3DR07; Q2M1U4; Q4VXX5; Q9BWT9; Q9UC85;
DT   01-NOV-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   10-MAY-2017, entry version 197.
DE   RecName: Full=Catalase;
DE            EC=1.11.1.6;
GN   Name=CAT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3755525; DOI=10.1093/nar/14.13.5321;
RA   Quan F., Korneluk R.G., Tropak M.B., Gravel R.A.;
RT   "Isolation and characterization of the human catalase gene.";
RL   Nucleic Acids Res. 14:5321-5335(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Kidney;
RX   PubMed=3755526;
RA   Bell G.I., Najarian R.C., Mullenbach G.T., Hallewell R.A.;
RT   "cDNA sequence coding for human kidney catalase.";
RL   Nucleic Acids Res. 14:5561-5562(1986).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=11728823; DOI=10.1016/S0891-5849(01)00734-1;
RA   Jin L.H., Bahn J.H., Eum W.S., Kwon H.Y., Jang S.H., Han K.H.,
RA   Kang T.-C., Won M.H., Kang J.H., Cho S.-W., Park J., Choi S.Y.;
RT   "Transduction of human catalase mediated by an HIV-1 TAT protein basic
RT   domain and arginine-rich peptides into mammalian cells.";
RL   Free Radic. Biol. Med. 31:1509-1519(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta, and Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   SeattleSNPs variation discovery resource;
RL   Submitted (FEB-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-22.
RX   PubMed=8282800; DOI=10.1172/JCI116959;
RA   Yoo J.-H., Erzurum S.C., Hay J.G., Lemarchand P., Crystal R.G.;
RT   "Vulnerability of the human airway epithelium to hyperoxia.
RT   Constitutive expression of the catalase gene in human bronchial
RT   epithelial cells despite oxidant stress.";
RL   J. Clin. Invest. 93:297-302(1994).
RN   [10]
RP   PROTEIN SEQUENCE OF 2-19.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [11]
RP   PROTEIN SEQUENCE OF 24-38; 99-105; 307-315 AND 469-476, FUNCTION, AND
RP   CATALYTIC ACTIVITY.
RC   TISSUE=Erythrocyte;
RX   PubMed=7882369;
RA   Takeuchi A., Miyamoto T., Yamaji K., Masuho Y., Hayashi M.,
RA   Hayashi H., Onozaki K.;
RT   "A human erythrocyte-derived growth-promoting factor with a wide
RT   target cell spectrum: identification as catalase.";
RL   Cancer Res. 55:1586-1589(1995).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 77-527.
RC   TISSUE=Fibroblast;
RX   PubMed=6548744;
RA   Korneluk R.G., Quan F., Lewis W.H., Guise K.S., Willard H.F.,
RA   Holmes M.T., Gravel R.A.;
RT   "Isolation of human fibroblast catalase cDNA clones. Sequence of
RT   clones derived from spliced and unspliced mRNA.";
RL   J. Biol. Chem. 259:13819-13823(1984).
RN   [13]
RP   PROTEIN SEQUENCE OF 445-456, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Vishwanath V.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [14]
RP   INVOLVEMENT IN ACATLAS.
RX   PubMed=2308162; DOI=10.1016/0022-2836(90)90359-T;
RA   Wen J.K., Osumi T., Hashimoto T., Ogata M.;
RT   "Molecular analysis of human acatalasemia. Identification of a
RT   splicing mutation.";
RL   J. Mol. Biol. 211:383-393(1990).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-515, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-9; SER-422; THR-511;
RP   SER-515 AND SER-517, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.75 ANGSTROMS).
RX   PubMed=10666617; DOI=10.1107/S0907444999015930;
RA   Ko T.P., Safo M.K., Musayev F.N., Di Salvo M.L., Wang C., Wu S.H.,
RA   Abraham D.J.;
RT   "Structure of human erythrocyte catalase.";
RL   Acta Crystallogr. D 56:241-245(2000).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS).
RX   PubMed=10656833; DOI=10.1006/jmbi.1999.3458;
RA   Putnam C.D., Arvai A.S., Bourne Y., Tainer J.A.;
RT   "Active and inhibited human catalase structures: ligand and NADPH
RT   binding and catalytic mechanism.";
RL   J. Mol. Biol. 296:295-309(2000).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS).
RX   PubMed=11134921; DOI=10.1107/S0907444900013767;
RA   Safo M.K., Musayev F.N., Wu S.H., Abraham D.J., Ko T.P.;
RT   "Structure of tetragonal crystals of human erythrocyte catalase.";
RL   Acta Crystallogr. D 57:1-7(2001).
CC   -!- FUNCTION: Occurs in almost all aerobically respiring organisms and
CC       serves to protect cells from the toxic effects of hydrogen
CC       peroxide. Promotes growth of cells including T-cells, B-cells,
CC       myeloid leukemia cells, melanoma cells, mastocytoma cells and
CC       normal and transformed fibroblast cells.
CC       {ECO:0000269|PubMed:7882369}.
CC   -!- CATALYTIC ACTIVITY: 2 H(2)O(2) = O(2) + 2 H(2)O.
CC       {ECO:0000255|PROSITE-ProRule:PRU10013,
CC       ECO:0000269|PubMed:7882369}.
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC   -!- COFACTOR:
CC       Name=NADP(+); Xref=ChEBI:CHEBI:58349;
CC   -!- SUBUNIT: Homotetramer.
CC   -!- SUBCELLULAR LOCATION: Peroxisome.
CC   -!- PTM: The N-terminus is blocked.
CC   -!- DISEASE: Acatalasemia (ACATLAS) [MIM:614097]: A metabolic disorder
CC       characterized by a total or near total loss of catalase activity
CC       in red cells. It is often associated with ulcerating oral lesions.
CC       {ECO:0000269|PubMed:2308162}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the catalase family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Catalase entry;
CC       URL="https://en.wikipedia.org/wiki/Catalase";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/cat/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X04085; CAA27721.1; -; Genomic_DNA.
DR   EMBL; X04086; CAA27721.1; JOINED; Genomic_DNA.
DR   EMBL; X04087; CAA27721.1; JOINED; Genomic_DNA.
DR   EMBL; X04088; CAA27721.1; JOINED; Genomic_DNA.
DR   EMBL; X04089; CAA27721.1; JOINED; Genomic_DNA.
DR   EMBL; X04090; CAA27721.1; JOINED; Genomic_DNA.
DR   EMBL; X04091; CAA27721.1; JOINED; Genomic_DNA.
DR   EMBL; X04092; CAA27721.1; JOINED; Genomic_DNA.
DR   EMBL; X04093; CAA27721.1; JOINED; Genomic_DNA.
DR   EMBL; X04094; CAA27721.1; JOINED; Genomic_DNA.
DR   EMBL; X04095; CAA27721.1; JOINED; Genomic_DNA.
DR   EMBL; X04096; CAA27721.1; JOINED; Genomic_DNA.
DR   EMBL; X04076; CAA27717.1; -; mRNA.
DR   EMBL; AY028632; AAK29181.1; -; mRNA.
DR   EMBL; AK291585; BAF84274.1; -; mRNA.
DR   EMBL; AK315350; BAG37746.1; -; mRNA.
DR   EMBL; AY545477; AAS37679.1; -; Genomic_DNA.
DR   EMBL; AL035079; CAB45236.1; -; Genomic_DNA.
DR   EMBL; CH471064; EAW68170.1; -; Genomic_DNA.
DR   EMBL; CH471064; EAW68171.1; -; Genomic_DNA.
DR   EMBL; BC110398; AAI10399.1; -; mRNA.
DR   EMBL; BC112217; AAI12218.1; -; mRNA.
DR   EMBL; BC112219; AAI12220.1; -; mRNA.
DR   EMBL; L13609; AAA16651.1; -; Genomic_DNA.
DR   EMBL; K02400; AAB59522.1; -; Genomic_DNA.
DR   CCDS; CCDS7891.1; -.
DR   PIR; A23646; CSHU.
DR   RefSeq; NP_001743.1; NM_001752.3.
DR   UniGene; Hs.502302; -.
DR   PDB; 1DGB; X-ray; 2.20 A; A/B/C/D=4-501.
DR   PDB; 1DGF; X-ray; 1.50 A; A/B/C/D=5-501.
DR   PDB; 1DGG; X-ray; 1.80 A; A/B/C/D=5-501.
DR   PDB; 1DGH; X-ray; 2.00 A; A/B/C/D=4-501.
DR   PDB; 1F4J; X-ray; 2.40 A; A/B/C/D=1-527.
DR   PDB; 1QQW; X-ray; 2.75 A; A/B/C/D=1-527.
DR   PDBsum; 1DGB; -.
DR   PDBsum; 1DGF; -.
DR   PDBsum; 1DGG; -.
DR   PDBsum; 1DGH; -.
DR   PDBsum; 1F4J; -.
DR   PDBsum; 1QQW; -.
DR   ProteinModelPortal; P04040; -.
DR   SMR; P04040; -.
DR   BioGrid; 107297; 48.
DR   IntAct; P04040; 21.
DR   MINT; MINT-1210583; -.
DR   STRING; 9606.ENSP00000241052; -.
DR   BindingDB; P04040; -.
DR   ChEMBL; CHEMBL3627594; -.
DR   DrugBank; DB01213; Fomepizole.
DR   PeroxiBase; 5282; HsKat01.
DR   iPTMnet; P04040; -.
DR   PhosphoSitePlus; P04040; -.
DR   SwissPalm; P04040; -.
DR   BioMuta; CAT; -.
DR   DMDM; 115702; -.
DR   OGP; P04040; -.
DR   REPRODUCTION-2DPAGE; IPI00465436; -.
DR   REPRODUCTION-2DPAGE; P04040; -.
DR   SWISS-2DPAGE; P04040; -.
DR   EPD; P04040; -.
DR   MaxQB; P04040; -.
DR   PaxDb; P04040; -.
DR   PeptideAtlas; P04040; -.
DR   PRIDE; P04040; -.
DR   DNASU; 847; -.
DR   Ensembl; ENST00000241052; ENSP00000241052; ENSG00000121691.
DR   GeneID; 847; -.
DR   KEGG; hsa:847; -.
DR   UCSC; uc001mvm.4; human.
DR   CTD; 847; -.
DR   DisGeNET; 847; -.
DR   GeneCards; CAT; -.
DR   H-InvDB; HIX0009550; -.
DR   HGNC; HGNC:1516; CAT.
DR   HPA; CAB001515; -.
DR   HPA; HPA051282; -.
DR   HPA; HPA055838; -.
DR   MalaCards; CAT; -.
DR   MIM; 115500; gene.
DR   MIM; 614097; phenotype.
DR   neXtProt; NX_P04040; -.
DR   OpenTargets; ENSG00000121691; -.
DR   Orphanet; 926; Acatalasemia.
DR   PharmGKB; PA26099; -.
DR   eggNOG; KOG0047; Eukaryota.
DR   eggNOG; COG0753; LUCA.
DR   GeneTree; ENSGT00390000018100; -.
DR   HOVERGEN; HBG003986; -.
DR   InParanoid; P04040; -.
DR   KO; K03781; -.
DR   OMA; WDYRADD; -.
DR   OrthoDB; EOG091G04V5; -.
DR   PhylomeDB; P04040; -.
DR   TreeFam; TF300540; -.
DR   BioCyc; MetaCyc:MONOMER66-341; -.
DR   BRENDA; 1.11.1.6; 2681.
DR   Reactome; R-HSA-3299685; Detoxification of Reactive Oxygen Species.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-74259; Purine catabolism.
DR   SABIO-RK; P04040; -.
DR   SIGNOR; P04040; -.
DR   ChiTaRS; CAT; human.
DR   EvolutionaryTrace; P04040; -.
DR   GeneWiki; Catalase; -.
DR   GenomeRNAi; 847; -.
DR   PRO; PR:P04040; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000121691; -.
DR   CleanEx; HS_CAT; -.
DR   Genevisible; P04040; HS.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IEA:Ensembl.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:Ensembl.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005764; C:lysosome; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005758; C:mitochondrial intermembrane space; IEA:Ensembl.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0005782; C:peroxisomal matrix; TAS:Reactome.
DR   GO; GO:0005778; C:peroxisomal membrane; ISS:UniProtKB.
DR   GO; GO:0005777; C:peroxisome; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IEA:Ensembl.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0004046; F:aminoacylase activity; IEA:Ensembl.
DR   GO; GO:0016209; F:antioxidant activity; IDA:UniProtKB.
DR   GO; GO:0004096; F:catalase activity; IDA:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0020037; F:heme binding; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0050661; F:NADP binding; IDA:UniProtKB.
DR   GO; GO:0016684; F:oxidoreductase activity, acting on peroxide as acceptor; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0005102; F:receptor binding; IPI:UniProtKB.
DR   GO; GO:0009060; P:aerobic respiration; IEA:Ensembl.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; IEA:Ensembl.
DR   GO; GO:0008203; P:cholesterol metabolic process; IEA:Ensembl.
DR   GO; GO:0020027; P:hemoglobin metabolic process; IEA:Ensembl.
DR   GO; GO:0042744; P:hydrogen peroxide catabolic process; IDA:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IEA:Ensembl.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0001649; P:osteoblast differentiation; IDA:UniProtKB.
DR   GO; GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IEA:Ensembl.
DR   GO; GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IEA:Ensembl.
DR   GO; GO:0051289; P:protein homotetramerization; IDA:UniProtKB.
DR   GO; GO:0051262; P:protein tetramerization; IDA:UniProtKB.
DR   GO; GO:0006195; P:purine nucleotide catabolic process; TAS:Reactome.
DR   GO; GO:0014823; P:response to activity; IEA:Ensembl.
DR   GO; GO:0046686; P:response to cadmium ion; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:0070542; P:response to fatty acid; IEA:Ensembl.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IBA:GO_Central.
DR   GO; GO:0055093; P:response to hyperoxia; IEA:Ensembl.
DR   GO; GO:0001666; P:response to hypoxia; IEA:Ensembl.
DR   GO; GO:0014854; P:response to inactivity; IEA:Ensembl.
DR   GO; GO:0032868; P:response to insulin; IEA:Ensembl.
DR   GO; GO:0033591; P:response to L-ascorbic acid; IEA:Ensembl.
DR   GO; GO:0010288; P:response to lead ion; IEA:Ensembl.
DR   GO; GO:0009642; P:response to light intensity; IEA:Ensembl.
DR   GO; GO:0010193; P:response to ozone; IEA:Ensembl.
DR   GO; GO:0080184; P:response to phenylpropanoid; IEA:Ensembl.
DR   GO; GO:0000302; P:response to reactive oxygen species; IMP:UniProtKB.
DR   GO; GO:0033189; P:response to vitamin A; IEA:Ensembl.
DR   GO; GO:0033197; P:response to vitamin E; IEA:Ensembl.
DR   GO; GO:0006641; P:triglyceride metabolic process; IEA:Ensembl.
DR   GO; GO:0001657; P:ureteric bud development; IEA:Ensembl.
DR   GO; GO:0009650; P:UV protection; IMP:UniProtKB.
DR   Gene3D; 2.40.180.10; -; 1.
DR   InterPro; IPR018028; Catalase.
DR   InterPro; IPR020835; Catalase-like_dom.
DR   InterPro; IPR024708; Catalase_AS.
DR   InterPro; IPR024711; Catalase_clade1/3.
DR   InterPro; IPR011614; Catalase_core.
DR   InterPro; IPR002226; Catalase_haem_BS.
DR   InterPro; IPR010582; Catalase_immune_responsive.
DR   PANTHER; PTHR11465; PTHR11465; 1.
DR   Pfam; PF00199; Catalase; 1.
DR   Pfam; PF06628; Catalase-rel; 1.
DR   PIRSF; PIRSF038928; Catalase_clade1-3; 1.
DR   PRINTS; PR00067; CATALASE.
DR   SMART; SM01060; Catalase; 1.
DR   SUPFAM; SSF56634; SSF56634; 1.
DR   PROSITE; PS00437; CATALASE_1; 1.
DR   PROSITE; PS00438; CATALASE_2; 1.
DR   PROSITE; PS51402; CATALASE_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome;
KW   Direct protein sequencing; Heme; Hydrogen peroxide; Iron;
KW   Metal-binding; Mitogen; NADP; Oxidoreductase; Peroxidase; Peroxisome;
KW   Phosphoprotein; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|PubMed:12665801}.
FT   CHAIN         2    527       Catalase.
FT                                /FTId=PRO_0000084901.
FT   ACT_SITE     75     75
FT   ACT_SITE    148    148
FT   METAL       358    358       Iron (heme axial ligand).
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:25944712}.
FT   MOD_RES       9      9       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     221    221       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P24270}.
FT   MOD_RES     233    233       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P24270}.
FT   MOD_RES     306    306       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P24270}.
FT   MOD_RES     306    306       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P24270}.
FT   MOD_RES     417    417       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P24270}.
FT   MOD_RES     422    422       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     480    480       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P24270}.
FT   MOD_RES     480    480       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P24270}.
FT   MOD_RES     499    499       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P24270}.
FT   MOD_RES     511    511       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     515    515       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     517    517       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CONFLICT     54     54       D -> N (in Ref. 3; AAK29181).
FT                                {ECO:0000305}.
FT   CONFLICT    100    100       F -> L (in Ref. 4; BAG37746).
FT                                {ECO:0000305}.
FT   CONFLICT    239    239       D -> G (in Ref. 3; AAK29181).
FT                                {ECO:0000305}.
FT   CONFLICT    274    274       Y -> D (in Ref. 3; AAK29181).
FT                                {ECO:0000305}.
FT   CONFLICT    301    301       K -> R (in Ref. 3; AAK29181).
FT                                {ECO:0000305}.
FT   CONFLICT    366    366       L -> P (in Ref. 4; BAG37746).
FT                                {ECO:0000305}.
FT   CONFLICT    449    449       N -> D (in Ref. 4; BAG37746).
FT                                {ECO:0000305}.
FT   CONFLICT    514    514       Q -> R (in Ref. 3; AAK29181).
FT                                {ECO:0000305}.
FT   CONFLICT    520    520       A -> V (in Ref. 3; AAK29181).
FT                                {ECO:0000305}.
FT   TURN          7     10       {ECO:0000244|PDB:1DGF}.
FT   HELIX        11     18       {ECO:0000244|PDB:1DGF}.
FT   TURN         19     21       {ECO:0000244|PDB:1DGF}.
FT   STRAND       30     32       {ECO:0000244|PDB:1QQW}.
FT   STRAND       38     40       {ECO:0000244|PDB:1DGF}.
FT   STRAND       42     45       {ECO:0000244|PDB:1DGF}.
FT   HELIX        55     64       {ECO:0000244|PDB:1DGF}.
FT   STRAND       73     75       {ECO:0000244|PDB:1F4J}.
FT   STRAND       77     87       {ECO:0000244|PDB:1DGF}.
FT   TURN         92     94       {ECO:0000244|PDB:1DGF}.
FT   HELIX        98    100       {ECO:0000244|PDB:1DGF}.
FT   STRAND      106    114       {ECO:0000244|PDB:1DGF}.
FT   STRAND      116    118       {ECO:0000244|PDB:1DGF}.
FT   STRAND      124    128       {ECO:0000244|PDB:1DGF}.
FT   STRAND      131    138       {ECO:0000244|PDB:1DGF}.
FT   STRAND      141    152       {ECO:0000244|PDB:1DGF}.
FT   HELIX       158    160       {ECO:0000244|PDB:1DGF}.
FT   HELIX       161    168       {ECO:0000244|PDB:1DGF}.
FT   TURN        172    174       {ECO:0000244|PDB:1DGF}.
FT   HELIX       179    188       {ECO:0000244|PDB:1DGF}.
FT   HELIX       190    192       {ECO:0000244|PDB:1DGF}.
FT   HELIX       193    199       {ECO:0000244|PDB:1DGF}.
FT   HELIX       202    204       {ECO:0000244|PDB:1DGF}.
FT   STRAND      205    209       {ECO:0000244|PDB:1DGF}.
FT   STRAND      220    223       {ECO:0000244|PDB:1DGF}.
FT   STRAND      229    238       {ECO:0000244|PDB:1DGF}.
FT   HELIX       247    256       {ECO:0000244|PDB:1DGF}.
FT   HELIX       260    270       {ECO:0000244|PDB:1DGF}.
FT   STRAND      276    284       {ECO:0000244|PDB:1DGF}.
FT   HELIX       286    291       {ECO:0000244|PDB:1DGF}.
FT   TURN        305    307       {ECO:0000244|PDB:1DGF}.
FT   STRAND      311    320       {ECO:0000244|PDB:1DGF}.
FT   HELIX       325    328       {ECO:0000244|PDB:1DGF}.
FT   TURN        329    331       {ECO:0000244|PDB:1DGF}.
FT   STRAND      343    345       {ECO:0000244|PDB:1DGF}.
FT   HELIX       349    365       {ECO:0000244|PDB:1DGF}.
FT   HELIX       370    372       {ECO:0000244|PDB:1DGF}.
FT   HELIX       374    376       {ECO:0000244|PDB:1DGF}.
FT   TURN        397    400       {ECO:0000244|PDB:1DGF}.
FT   STRAND      404    406       {ECO:0000244|PDB:1DGF}.
FT   HELIX       416    418       {ECO:0000244|PDB:1DGF}.
FT   STRAND      427    431       {ECO:0000244|PDB:1DGF}.
FT   HELIX       441    449       {ECO:0000244|PDB:1DGF}.
FT   HELIX       453    467       {ECO:0000244|PDB:1DGF}.
FT   HELIX       472    485       {ECO:0000244|PDB:1DGF}.
FT   HELIX       487    500       {ECO:0000244|PDB:1DGF}.
SQ   SEQUENCE   527 AA;  59756 MW;  7BAA2394D124ED20 CRC64;
     MADSRDPASD QMQHWKEQRA AQKADVLTTG AGNPVGDKLN VITVGPRGPL LVQDVVFTDE
     MAHFDRERIP ERVVHAKGAG AFGYFEVTHD ITKYSKAKVF EHIGKKTPIA VRFSTVAGES
     GSADTVRDPR GFAVKFYTED GNWDLVGNNT PIFFIRDPIL FPSFIHSQKR NPQTHLKDPD
     MVWDFWSLRP ESLHQVSFLF SDRGIPDGHR HMNGYGSHTF KLVNANGEAV YCKFHYKTDQ
     GIKNLSVEDA ARLSQEDPDY GIRDLFNAIA TGKYPSWTFY IQVMTFNQAE TFPFNPFDLT
     KVWPHKDYPL IPVGKLVLNR NPVNYFAEVE QIAFDPSNMP PGIEASPDKM LQGRLFAYPD
     THRHRLGPNY LHIPVNCPYR ARVANYQRDG PMCMQDNQGG APNYYPNSFG APEQQPSALE
     HSIQYSGEVR RFNTANDDNV TQVRAFYVNV LNEEQRKRLC ENIAGHLKDA QIFIQKKAVK
     NFTEVHPDYG SHIQALLDKY NAEKPKNAIH TFVQSGSHLA AREKANL
//
